Drug details

Litfulo (ritlecitinib capsules)

type of Antineoplastic Tyrosine Kinase Inhibitors, Dermatologics, Other

Litfulo (ritlecitinib) is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

This drug may have the following side effects:
  • hives,
  • rash,
  • diarrhea,
  • fever,
  • dizziness,
  • headache,
  • acne,
  • swelling and sores inside the mouth.
  • “hair bumps” (folliculitis),
  • skin itching and inflammation (atopic dermatitis),
  • increased blood creatine phosphokinase,
  • herpes zoster,
  • decreased red blood cell count, and